# Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead

> **NCT07273656** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University Hospital, Lille** · enrollment: 59 (estimated)

## Conditions studied

- Keratosis
- Actinic Keratoses

## Interventions

- **DRUG:** Cryotherapy + Tirbanibulin

## Key facts

- **NCT ID:** NCT07273656
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-11-30
- **Primary completion:** 2027-11-30
- **Final completion:** 2027-11-30
- **Target enrollment:** 59 (ESTIMATED)
- **Last updated:** 2025-12-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07273656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07273656, "Efficacy and Safety of Cryotherapy Followed by Tirbanibulin Ointment for Actinic Keratosis on the Scalp and Forehead". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07273656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*